Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn clinical trials, adults taking semaglutide 2.4mg lost an average of around 15% of their body weight over 68 weeks alongside a reduced-calorie diet and increased activity — roughly 15–16 kg for someone starting at 100 kg. How much you lose on semaglutide in practice depends on your starting weight, how long you stay on treatment, and whether lifestyle changes run alongside it. Semaglutide (sold as Wegovy for weight management) is a prescription-only medicine; a qualified prescriber assesses whether it is clinically suitable before any treatment begins. That clinical step is not optional, and it matters for results as much as it does for safety.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people arrive at the question of semaglutide results having already decided that the highest dose must produce the best outcome for them personally. That's understandable, and it's also where the thinking can go sideways. Trial averages are exactly that, averages drawn from thousands of participants. The STEP 1 trial, published in the New England Journal of Medicine, reported roughly 15% average body-weight reduction over 68 weeks at the 2.4mg maintenance dose, alongside diet and activity changes. Some participants lost considerably more; others less. Genetics, baseline weight, how consistently treatment runs, and what happens alongside the pen all feed into where any individual lands. A prescriber who knows your full picture is far better placed to set realistic expectations than a headline percentage. That doesn't mean the data is unimpressive, 15% average over 68 weeks, in a well-controlled trial, is a substantial clinical result. It just means the number is a range, not a promise, and it's worth holding it that way.
Early in treatment, when doses are low for tolerability reasons, weight change tends to be modest. The titration schedule works up gradually, and the months on the maintenance dose tend to show the greatest effect. So asking how much you lose on semaglutide in a month produces a different answer depending on which month you mean. Across the full 68-week STEP 1 period, the average monthly rate of loss was roughly 0.9–1.0 kg, but that flattens out a ramp that starts gently and steepens as the dose increases. People who stay on treatment longer, maintain the lifestyle changes their prescriber recommended, and keep their clinical support in place tend to do better. Those who stop early because of side effects, or who treat the injection as a standalone fix, tend to see results tail off. The clinical support element is not a soft add-on. It's part of the mechanism.
For a fuller breakdown of what individual factors affect total loss when taking semaglutide, this page explores the variables in more detail.
UK private treatment prices for semaglutide vary between providers and by dose. Since Novo Nordisk's pricing moves and broader market changes through 2025, typical private prices have ranged from roughly £149 to over £300 per month depending on dose and provider, these figures are widely reported and should be treated as indicative rather than fixed. A detailed breakdown of Wegovy pricing in the UK covers how those ranges work in practice.
What headline prices often omit: some providers charge separately for the initial consultation, the prescription itself, and delivery. Aftercare (the ongoing clinical support that actually influences your results) is sometimes absent entirely, or gated behind an additional fee. That matters because semaglutide is not a medicine you titrate and manage without clinical input; it's a prescription-only treatment requiring regular review. When comparing costs, the fair comparison is total cost of a supervised month, not the lowest listed pen price. See how to read a semaglutide quote honestly before committing to any provider.
For a prescription medicine, price is the wrong test. The MHRA has warned repeatedly about counterfeit weight-loss pens sold online and via social media, fake pens seized in the UK have contained insulin instead of semaglutide, and enforcement operations through 2025 removed around 20 million doses of illegally traded weight-loss medicines worth approximately £45m from the supply chain. A low price from an unverified seller is a red flag, not a bargain. You can verify any online pharmacy on the GPhC register, it takes thirty seconds and tells you immediately whether a pharmacy is regulated.
At nume, we are not the cheapest option. That's a deliberate choice. One price covers consultation, prescription, treatment, and free next-working-day DPD delivery in plain packaging. There are no hidden fees. You can explore what's included on our treatment page, and our about us page explains the clinical infrastructure behind the service. If you have questions before starting, our FAQs cover the most common ones, and our team is available seven days a week.
A small saving on a pen that arrives from an unverified source, with no prescriber review and no aftercare, answers the wrong question entirely. The right question is whether the care behind the medicine is good enough to produce the results you're looking for. Check your eligibility and start your free consultation with a prescriber who can give you a straight answer about what to expect.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.